MTLS Earnings

MTLS reported its earnings on 2026-02-19, showcasing a revenue of 82.44M against an estimate of 70.73M, resulting in a 16.56% surprise. The EPS was 0.12, surpassing the expected 0.01 by 1100%. The stock experienced a 9.44% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following MTLS's earnings announcement on 2026-02-19, the stock price moved by 9.44% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, MTLS's stock price tends to shift by an average of 4.25% in the 10 days leading up to earnings and -3.49% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate MTLS's annual revenue to reach 70.73M, while the EPS is projected at 0.06. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between MTLS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MTLS's stock price typically moves by 4.25% in the 10 days before its earnings and -3.49% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.06 and revenue of 70.73M.

Despite positive factors like a share buyback program and strong revenue growth in the Medical segment, challenges persist. The Manufacturing segment struggles with profitability and macroeconomic headwinds. The Software segment faces revenue declines due to its transition. Additionally, the company's dependence on key verticals and economic uncertainties pose risks. While financial metrics show improvement, the cautious outlook on manufacturing and strategic dependencies balance out the positives, leading to a neutral sentiment.